KPV 10mg

Performance Profile

• NF-kB Pathway Inhibition: Inhibits NF-kB — one of the body’s main inflammatory signalling switches — in systemic inflammation research models. A well-studied mechanism for understanding how inflammatory pathways can be modulated.
• Gut Mucosal Research: Uses the PepT1 transporter to reach intestinal mucosal cells — investigated for effects on gut lining integrity and intestinal permeability models.
• Dermal Inflammation Research: In vitro antimicrobial activity observed against dermal pathogens; studied in inflammatory skin cell models.
• Immune Pathway Activity: Investigated for pathogen neutralisation mechanisms in immune pathway models — without documented suppression of baseline immune response.

Quick Summary

• Best For: Inflammatory pathway research, gut mucosal models, dermal cell studies.
• Use Case: Investigating gut mucosal or systemic inflammatory pathway modulation in preclinical research models.
• Commonly Studied With: BPC-157 in gastrointestinal repair and barrier function research.

For research purposes only. Not for human consumption. For use by licensed researchers only. These compounds have not been evaluated or approved by Health Canada for human use.